Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver (Q77134058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

M D Adams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P Raman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R L Judd

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1915-1920

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of NIDDM. A balanced overview

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

In vitro effects of sulfonylurea on glucose transport and translocation of glucose transporters in adipocytes from streptozocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Ciglitazone, a New Hypoglycemic Agent: I. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Actions of the novel antidiabetic agent englitazone in rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Interaction of mixed-function oxidation with biosynthetic processes. 1. Inhibition of gluconeogenesis by aminopyrine in perfused rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

In vitro studies on the action of CS-045, a new antidiabetic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Role of fructose 2,6-bisphosphate in the control by glucagon of gluconeogenesis from various precursors in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Effect of tolbutamide and glyburide on pyruvate kinase flux in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Insulin sensitization in diabetic rat liver by an antihyperglycemic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

Glucose transport-enhancing and hypoglycemic activity of 2-methyl-2-phenoxy-3-phenylpropanoic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900052-5

10.1016/S0006-2952(98)00052-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9714310%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference